Bb Biotech as of June 30, 2017
Portfolio Holdings for Bb Biotech
Bb Biotech holds 28 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 13.5 | $443M | 3.5M | 125.91 | |
| Celgene Corporation | 12.9 | $422M | 3.2M | 129.87 | |
| Ionis Pharmaceuticals (IONS) | 11.4 | $374M | 7.4M | 50.87 | |
| Radius Health | 7.0 | $228M | 5.0M | 45.23 | |
| Gilead Sciences (GILD) | 6.0 | $196M | 2.8M | 70.78 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.8 | $190M | 1.5M | 128.87 | |
| Alexion Pharmaceuticals | 5.0 | $165M | 1.4M | 121.67 | |
| Neurocrine Biosciences (NBIX) | 4.8 | $159M | 3.4M | 46.00 | |
| Agios Pharmaceuticals (AGIO) | 4.5 | $148M | 2.9M | 51.45 | |
| Tesaro | 3.8 | $123M | 878k | 139.86 | |
| Halozyme Therapeutics (HALO) | 3.2 | $106M | 8.3M | 12.82 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $97M | 1.2M | 79.76 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $88M | 180k | 491.14 | |
| Sage Therapeutics (SAGE) | 2.2 | $72M | 907k | 79.64 | |
| Esperion Therapeutics (ESPR) | 2.1 | $70M | 1.5M | 46.28 | |
| Kite Pharma | 2.0 | $66M | 640k | 103.67 | |
| Juno Therapeutics | 2.0 | $65M | 2.2M | 29.89 | |
| Macrogenics (MGNX) | 1.3 | $41M | 2.4M | 17.51 | |
| Myovant Sciences | 1.2 | $39M | 3.3M | 11.70 | |
| Avexis | 1.0 | $33M | 403k | 82.16 | |
| Intercept Pharmaceuticals In | 0.9 | $31M | 256k | 121.07 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $27M | 2.2M | 12.42 | |
| Five Prime Therapeutics | 0.7 | $23M | 778k | 30.11 | |
| Alder Biopharmaceuticals | 0.7 | $22M | 1.9M | 11.45 | |
| Prothena (PRTA) | 0.6 | $19M | 350k | 54.12 | |
| Novavax | 0.3 | $9.6M | 8.3M | 1.15 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $8.3M | 1.1M | 7.50 | |
| Achillion Pharmaceuticals | 0.2 | $5.9M | 1.3M | 4.59 |
